CTF1 and metabolic syndrome: Conversely, it has also been reported that CT-1 deficient mice had impaired metabolic features and administering CT-1 could reverse insulin resistance in obese mice, concluding that CT-1 had potential applications in the treatment of obesity and the MetS [12,24].